![Cord Dohrmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cord Dohrmann
Directeur Technique/Scientifique/R&D chez
EVOTEC SE
Fortune : 749 695 $ au 31/07/2026
Profil
Cord E.
Dohrmann is Co-Managing Director at Evotec International GmbH.
Dr. Dohrmann is Non-Executive Director at FSHD Unlimited Cooperatie Ua since 2017.
Dr. Dohrmann is Non-Executive Director at Facio Therapies.
Dr. Dohrmann is Chief Scientific Officer at Evotec SE since 2010.
Dr. Dohrmann is Member-Supervisory Board at Eternygen GmbH.
Dr. Dohrmann is Member at German Council of Science & Humanities.
Dr. Dohrmann is Member-Supervisory Board at Breakpoint Therapeutics GmbH.
Former roles include Chief Executive Officer at DeveloGen AG from 2009 to 2012.
Dr. Dohrmann was Principal at Duke University, The General Hospital Corp., and Eberhard Karls Universität Tübingen.
Education includes undergraduate degree from Eberhard Karls Universität Tübingen in 1987, graduate degree from Max-Planck-Institute for Molecular Genetics, and doctorate from Harvard Medical School in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOTEC SE 0,11 % | 31/12/2025 | 191 084 ( 0,11 % ) | 749 695 $ | 31/07/2026 |
Postes actifs de Cord Dohrmann
| Sociétés | Poste | Début |
|---|---|---|
| EVOTEC SE | Directeur Technique/Scientifique/R&D | 01/09/2010 |
Eternygen GmbH
 Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs | Directeur/Membre du Conseil | - |
FSHD Unlimited Cooperatie Ua
 FSHD Unlimited Cooperatie Ua Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company with a focus on facioscapulohumeral dystrophy | Directeur/Membre du Conseil | 01/06/2017 |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Directeur Général | - |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Directeur/Membre du Conseil | - |
Facio Therapies
 Facio Therapies Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | - |
German Council of Science & Humanities | Corporate Officer/Principal | - |
Anciens postes connus de Cord Dohrmann
| Sociétés | Poste | Fin |
|---|---|---|
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Directeur Général | 25/01/2012 |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Cord Dohrmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
DeveloGen AG
DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Health Technology |
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eternygen GmbH
Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs | Health Technology |
German Council of Science & Humanities | |
FSHD Unlimited Cooperatie Ua
FSHD Unlimited Cooperatie Ua Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company with a focus on facioscapulohumeral dystrophy | Health Technology |
Facio Therapies
Facio Therapies Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Health Technology |
